SE469368B - Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms) - Google Patents

Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms)

Info

Publication number
SE469368B
SE469368B SE9102909A SE9102909A SE469368B SE 469368 B SE469368 B SE 469368B SE 9102909 A SE9102909 A SE 9102909A SE 9102909 A SE9102909 A SE 9102909A SE 469368 B SE469368 B SE 469368B
Authority
SE
Sweden
Prior art keywords
treatment
linomide
multiple sclerosis
mice
manufacture
Prior art date
Application number
SE9102909A
Other languages
English (en)
Swedish (sv)
Other versions
SE9102909D0 (sv
SE9102909L (sv
Inventor
O Abramsky
D Karussis
D Lehamann
S Slavin
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE9102909A priority Critical patent/SE469368B/sv
Publication of SE9102909D0 publication Critical patent/SE9102909D0/xx
Priority to CA002120712A priority patent/CA2120712A1/en
Priority to PCT/SE1992/000705 priority patent/WO1993006829A1/en
Priority to US08/211,579 priority patent/US5580882A/en
Priority to KR1019940701161A priority patent/KR940702726A/ko
Priority to AU27708/92A priority patent/AU653647B2/en
Priority to EP92921605A priority patent/EP0607282A1/en
Priority to PT100937A priority patent/PT100937A/pt
Priority to JP5506847A priority patent/JPH06511488A/ja
Publication of SE9102909L publication Critical patent/SE9102909L/xx
Publication of SE469368B publication Critical patent/SE469368B/sv
Priority to NO941273A priority patent/NO941273L/no
Priority to EE9400257A priority patent/EE9400257A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9102909A 1991-10-09 1991-10-09 Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms) SE469368B (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9102909A SE469368B (sv) 1991-10-09 1991-10-09 Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms)
JP5506847A JPH06511488A (ja) 1991-10-09 1992-10-08 置換キノリンカルボキシアミドの新規な使用
KR1019940701161A KR940702726A (ko) 1991-10-09 1992-10-08 치환된 퀴놀린-3-카르복시아미드 화합물의 용도 및 이를 이용한 다발성 경화증의 치료방법
PCT/SE1992/000705 WO1993006829A1 (en) 1991-10-09 1992-10-08 New use of substituted quinoline carboxamide
US08/211,579 US5580882A (en) 1991-10-09 1992-10-08 Use of substituted quinoline carboxamide
CA002120712A CA2120712A1 (en) 1991-10-09 1992-10-08 New use of substituted quinoline carboxamide
AU27708/92A AU653647B2 (en) 1991-10-09 1992-10-08 New use of substituted quinoline carboxamide
EP92921605A EP0607282A1 (en) 1991-10-09 1992-10-08 New use of substituted quinoline carboxamide
PT100937A PT100937A (pt) 1991-10-09 1992-10-08 Composicoes farmaceuticas contendo novas carboxamidas de quinolina susbstituidas
NO941273A NO941273L (no) 1991-10-09 1994-04-08 Ny anvendelse av substituert kinolinkarboksamid
EE9400257A EE9400257A (et) 1991-10-09 1994-11-17 Kinoliin-3-karboksamiidi ühendi kasutamine ravimkompositsiooni valmistamiseks

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9102909A SE469368B (sv) 1991-10-09 1991-10-09 Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms)

Publications (3)

Publication Number Publication Date
SE9102909D0 SE9102909D0 (sv) 1991-10-09
SE9102909L SE9102909L (sv) 1993-04-10
SE469368B true SE469368B (sv) 1993-06-28

Family

ID=20383935

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9102909A SE469368B (sv) 1991-10-09 1991-10-09 Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms)

Country Status (11)

Country Link
US (1) US5580882A (et)
EP (1) EP0607282A1 (et)
JP (1) JPH06511488A (et)
KR (1) KR940702726A (et)
AU (1) AU653647B2 (et)
CA (1) CA2120712A1 (et)
EE (1) EE9400257A (et)
NO (1) NO941273L (et)
PT (1) PT100937A (et)
SE (1) SE469368B (et)
WO (1) WO1993006829A1 (et)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302490D0 (sv) * 1993-07-26 1993-07-26 Kabi Pharmacia Ab New use of old drugs
SE9400810D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of Quinoline-3-carboxamide compounds
SE9400809D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of quinoline-3-carboxamide compounds
EP0685466A1 (de) * 1994-06-02 1995-12-06 Ciba-Geigy Ag 3-Heteroaliphatyl- und 3-Hetero-(aryl)aliphatyl-2(1H)-chinolonderivate
US5837815A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polypeptide products
EP0936866A4 (en) * 1996-10-28 2001-04-11 Dept Of The Army Us Government COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING ANTIBIOTIC RESIST INFECTIONS
JP4120713B2 (ja) * 1997-09-04 2008-07-16 大塚製薬株式会社 多発性硬化症治療剤
US6077851A (en) * 1998-04-27 2000-06-20 Active Biotech Ab Quinoline derivatives
SE9802550D0 (sv) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
SE9802549D0 (sv) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
US6133285A (en) * 1998-07-15 2000-10-17 Active Biotech Ab Quinoline derivatives
US6861442B1 (en) * 1998-12-30 2005-03-01 Sugen, Inc. PYK2 and inflammation
BR112013007850A2 (pt) * 2010-10-14 2016-06-07 Immunahr Ab 1,2-diidro-4-hidróxi-2-oxo-quinolina-3-carboxanilidas como ativadores de ahr

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
US5310913A (en) * 1989-06-09 1994-05-10 Kabi Pharmacia Aktiebolag Derivatives of quinoline-3-carboxanilide

Also Published As

Publication number Publication date
EP0607282A1 (en) 1994-07-27
PT100937A (pt) 1994-01-31
CA2120712A1 (en) 1993-04-15
AU653647B2 (en) 1994-10-06
JPH06511488A (ja) 1994-12-22
EE9400257A (et) 1996-02-15
US5580882A (en) 1996-12-03
NO941273D0 (no) 1994-04-08
NO941273L (no) 1994-06-08
KR940702726A (ko) 1994-09-17
WO1993006829A1 (en) 1993-04-15
SE9102909D0 (sv) 1991-10-09
AU2770892A (en) 1993-05-03
SE9102909L (sv) 1993-04-10

Similar Documents

Publication Publication Date Title
Wu et al. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models
Pakkenberg et al. Clozapine in the treatment of tremor
DE69837324T2 (de) Behandlung der multiplen sklerose durch einnahme von copolymer-1
SE469368B (sv) Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms)
JPH07504888A (ja) ＣＤｗ５２−多発性硬化症の治療のための特異抗体
KR101987512B1 (ko) 자기 면역 질환 치료용 조성물 및 방법
Kataoka et al. Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy.
EP1469882B1 (en) Treatment of nervous system diseases with goat serum
Piccolo et al. Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment.
AU2003202093A1 (en) Treatment of MS with goat serum
Saphier et al. α-Interferon inhibits adrenocortical secretion via μ1-opioid receptors in the rat
CN109939119B (zh) 栀子苷在制备治疗多发性硬化症药物中的应用
WO2016127848A1 (zh) 绿原酸在制备预防和治疗原发性皮肤t细胞淋巴癌的药物中的用途
AU641002B2 (en) Method of treatment of retrovirus infections
KR101226605B1 (ko) 질병의 치료
WO2022052016A1 (en) Pharmaceutical compositions and uses thereof in treating parkinson's disease
Jacobs et al. Treatment of experimental ocular toxoplasmosis
KR20230050363A (ko) 질환의 치료에 있어서 btk 저해제의 용도
Sarmiento et al. Guillain-Barre syndrome following 2-chlorodeoxyadenosine treatment for Hairy Cell Leukemia
EP3621628A1 (en) Method for treating multiple sclerosis using arsenic trioxide
Rajasekariah et al. Response of pre-adult and adult stages of Trichuris muris to common anthelmintics in mice
CN112263572A (zh) 右旋氯胺酮在制备治疗脱髓鞘疾病药物中的应用
SU1261665A1 (ru) Способ лечени тимомегалии у детей
CN113181182A (zh) 伪石蒜碱在制备预防和/或治疗多发性硬化症的药物中的用途
RU2197990C2 (ru) Способ лечения лиц, страдающих от сепсиса

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 9102909-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 9102909-0

Format of ref document f/p: F